Alzheimer's disease detected in minutes: The blood test that can be a game-changer and how to do it
A groundbreaking blood test has been FDA-approved for early Alzheimer's detection, offering a less invasive and more accessible alternative to PET scans and spinal taps. This test measures p-Tau217 and beta-amyloid levels, accurately identifying Alzheimer's pathology in adults aged 55 and older showing cognitive decline. Early detection enables timely intervention with treatments like Leqembi and Kisunla, improving patient outcomes.
Most Recent